Android app Apple app link

Amylyx Pharmaceuticals, Inc. (AMLX) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$6.30

$0.27 (-4.11%)
Last update: 01:00 PM EST
Day's range
$5.98
Day's range
$6.58

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
06/24/2025 Guggenheim Seamus Fernandez $17.00 $6.41   165.21%
05/06/2025 Leerink Partners Marc Goodman $10.00 $4.65   115.05%
11/18/2024 Robert W. Baird Joel Beatty $11.00 $4.76   131.09%
10/23/2024 Bank of America Securities Geoff Meacham $10.00 $4.53   120.75%
10/18/2024 H.C. Wainwright Andrew Fein $8.00 $3.92   104.08%
10/18/2024 Leerink Partners Marc Goodman $4.00 $3.92   2.04%
05/14/2024 Mizuho Securities Graig Suvannavejh $3.00 $1.82   64.84%
04/11/2024 Robert W. Baird Joel Beatty $3.00 $2.46   21.95%
04/04/2024 Deutsche Bank Neena Bitritto-Garg $4.00 $2.62   52.96%
03/17/2024 Mizuho Securities Graig Suvannavejh $4.00 $3.24   23.46%

Amylyx Pharmaceuticals, Inc. FAQ's

Amylyx Pharmaceuticals, Inc. has been rated by research analysts at Guggenheim, Leerink Partners, Robert W. Baird, Bank of America Securities, H.C. Wainwright, Mizuho Securities in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.